Who Owns Arthrex?
Arthrex is the flagship brand of Arthrex Inc., a privately held orthopedic medical device company headquartered in Naples, Florida. It is wholly owned by its founder, Reinhold Schmieding, who started the company in 1981 in Munich, Germany. The brand covers more than a thousand arthroscopic and orthopedic product families sold in over 100 countries, with third-party estimates placing annual revenue around 3.2 billion dollars.
Who Owns Arthrex?
- Parent Company: Arthrex Inc.
- Ownership Type: Wholly owned
- Company Type: Privately Held
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Arthrex | Arthrex Inc. | Wholly owned |
Where to Buy
Disclosure: We may earn commission from purchases
Arthrex on AmazonAdvertisement
History of Arthrex
- Founded: 1981
- Founders: Reinhold Schmieding
Reinhold Schmieding founded Arthrex in Munich in 1981, initially as a distributor of arthroscopy instruments. He recognized that minimally invasive joint surgery was emerging faster than the tools available for it, having observed the field through his father's orthopedic practice.
The company moved to the United States and shifted from distribution to designing and manufacturing its own devices. The name comes from arthroscopy, the technique that has remained the brand's core identity for more than four decades.
Through the 1990s and 2000s Arthrex grew into a full product manufacturer, building a global network of subsidiaries and a surgeon training program that became its commercial signature. Its headquarters settled in Naples, Florida, where a large campus now combines offices, US manufacturing, and a training center that hosts thousands of visiting surgeons each year.
By the 2020s the brand had become one of the dominant names in sports medicine orthopedics, with more than 13,000 employees and products in over 100 countries. It continues to expand US manufacturing capacity under continued founder ownership.
Advertisement
About Arthrex Inc.
What does Arthrex own?
Arthrex owns orthopedic product lines including FiberWire sutures, SwiveLock anchors, biologics systems, and arthroscopy equipment. It sells under a single master brand and does not hold a portfolio of separate consumer brands.
Is Arthrex publicly traded?
No. Arthrex is a private company wholly owned by its founder and has never issued public stock.
Advertisement
Who founded Arthrex?
Reinhold Schmieding founded the company in Munich, Germany, in 1981 and remains its owner and president more than four decades later.
Where is Arthrex headquartered?
Its headquarters and main campus are in Naples, Florida, where it houses corporate offices, US manufacturing, and a large surgeon training center.
Advertisement
How many brands does Arthrex own?
It operates under a single Arthrex master brand, with named product families such as FiberWire and SwiveLock rather than distinct brands.
Who owns Arthrex?
Founder Reinhold Schmieding owns Arthrex outright. There are no outside shareholders, private equity investors, or public owners.
Advertisement
What is Arthrex's revenue?
As a private company Arthrex does not publish audited revenue. Third-party estimates place annual revenue at approximately 3.2 billion dollars, and it reports more than 13,000 employees globally.
- Founded: 1981
- Headquarters: Naples, Florida, USA
- Company Type: Privately Held
- Revenue: Approximately $3.2 billion (estimate, FY2025)
- Employees: More than 13,000
Where Is Arthrex Made / Based?
- Headquarters: Naples, Florida, USA
- Manufacturing / Operations: United States, Germany
Arthrex Categories & Tags
Arthrex Sustainability & Ethics
Arthrex reports sustainability efforts focused on its US manufacturing footprint and workforce development in Florida. It does not carry third-party consumer certifications, and its environmental programs are centered on its Naples campus operations.
The relevant compliance layer is medical device regulation. Products meet FDA and international standards, and its surgeon education programs operate within rules governing industry relationships with healthcare professionals.
Advertisement
Arthrex Recalls & Controversies
The brand has experienced routine device field actions and FDA communications typical of a large implant maker, but no major safety scandal. Its products carry ongoing post-market surveillance like all orthopedic devices.
As a private company it draws less public scrutiny than listed peers, though its concentration of founder control occasionally surfaces in industry coverage. Patent and trade litigation is a normal feature of its competitive environment rather than a defining controversy.
Arthrex Ownership: Pros & Cons
Advantages
- +Founder ownership enables long-term investment without shareholder pressure
- +Specialization in arthroscopy creates deep technical authority
- +Surgeon training model drives loyalty and repeat purchases
- +US manufacturing supports quality and supply control
- +Independence avoids M&A disruption
Considerations
- -Succession risk is concentrated in a single owner
- -No equity capital limits large acquisition options
- -Private status offers no public financial transparency
- -Broader orthopedic competitors can bundle wider portfolios
- -Founder age raises questions about long-term governance
Advertisement
Frequently Asked Questions About Arthrex
Sources & Further Reading
Advertisement
Competitors to Arthrex
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Intuitive Surgical | USA | 1995 | Mass market | Global | All Genders | |
| Smith Nephew | England | 1856 | Premium | Global | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsIntuitive Surgical
Owned by Intuitive Surgical, Inc.
The corporate brand of Intuitive Surgical, Inc., the Sunnyvale company behind the da Vinci robotic surgery systems and Ion bronchoscopy platform.
medical-devicesrobotic-surgeryhealthcare
Healthcare PharmaceuticalsSmith+Nephew
Owned by Smith+Nephew plc
British medical technology company founded in 1856, reporting $6.16 billion in FY2025 revenue across orthopaedics, sports medicine, and advanced wound management, listed on the London Stock Exchange.
medical-devicesorthopedicswound-care
Competitive Analysis
Market Positioning: Arthrex competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to Arthrex
Looking for brands with different ownership structures? These similar brands are not owned by Arthrex Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsSmith+Nephew
Owned by Smith+Nephew plc
British medical technology company founded in 1856, reporting $6.16 billion in FY2025 revenue across orthopaedics, sports medicine, and advanced wound management, listed on the London Stock Exchange.
medical-devicesorthopedicswound-care
Publicly Traded
Smith+Nephew operates independently without a large parent corporation.
Healthcare PharmaceuticalsIvoclar
Owned by Ivoclar Vivadent AG
Dental products brand of family-owned Ivoclar Vivadent AG, maker of IPS e.max ceramics and equipment sold in about 130 countries.
dental-productsdental-materialsmedical-devices
Privately Owned
Ivoclar operates independently without a large parent corporation.
Healthcare PharmaceuticalsPhilips
Owned by Koninklijke Philips N.V.
Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.
healthcare-technologyelectronicsmedical-devices
Publicly Traded
Philips operates independently without a large parent corporation.
Healthcare PharmaceuticalsZimmer Biomet
Owned by Zimmer Biomet Holdings, Inc.
Zimmer Biomet is the flagship orthopedic brand of Zimmer Biomet Holdings, producing knee, hip, and trauma implants plus the ROSA surgical robotics platform from its Warsaw, Indiana base.
orthopedicsmedical-devicesimplants
Publicly Traded
Zimmer Biomet operates independently without a large parent corporation.
Healthcare PharmaceuticalsGE HealthCare
Owned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
healthcare-technologymedical-imagingdiagnostics
Publicly Traded
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsHCA Healthcare
Owned by HCA Healthcare, Inc.
HCA Healthcare is the flagship brand of the largest U.S. for-profit hospital operator, a network of 190 hospitals and about 2,500 ambulatory sites across 19 states and England.
hospitalshealthcareemergency-care
Publicly Traded
HCA Healthcare operates independently without a large parent corporation.
Jobs at Arthrex Inc.
Advertisement
Latest News About Arthrex
Related Articles About Arthrex
View more articles
Health
Hospital and Clinic Brand Ownership
HCA Healthcare is the largest for-profit hospital system (190 hospitals, $75.6B revenue). Tenet has 50 hospitals ($21.3B). UHS has 346 behavioral facilities. Fresenius leads dialysis. Explore our database.
Who Brands StaffNov 14, 2026
Hca HealthcareTenet HealthUhs
Health
Eye Care Brand Ownership: Bausch & Lomb to Alcon
J&J Vision (Acuvue) leads contact lenses at 27-30%. Alcon (Novartis spin-off) holds 25-27%. CooperVision has 22-24%. Bausch + Lomb has 12-15%. EssilorLuxottica dominates lenses at 30.7%. Explore our database.
Who Brands StaffNov 13, 2026
Bausch LombAlconCoopervision
Health
Dental Brand Ownership Beyond Colgate and Crest
Colgate holds 41.3% global toothpaste share. P&G (Crest, Oral-B) has 14.1%. Haleon (Sensodyne) has 4.4%. Church & Dwight is the only independent at scale. The oral care market is $47.2B. Explore our database.
Who Brands StaffNov 12, 2026
ColgateCrestOral B
Advertisement
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandgenetic-testing
23andMe
Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.
Brand in Healthcare & Pharmaceuticals
dna-kitsconsumer-genomics
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandmedical-devices
Abbott Medical Devices
Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.
Brand in Healthcare & Pharmaceuticals
cardiovasculardiabetes-care